(Q64189152)

English

Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Drug Distribution and Pharmacodynamic Study of Pulsatile Lapatinib in Surgically Accessible EGFR-Amplified Recurrent High-Grade Glioma (English)

0 references

0 references

0 references

0 references

0 references

0 references

United States of America

0 references

start time

13 March 2014

0 references

end time

3 June 2019

0 references

number of participants

33

0 references

clinical trial phase

phase I clinical trial

0 references

research site

University of California, Los Angeles

0 references

Johns Hopkins University

0 references

Dana–Farber Cancer Institute

0 references

Memorial Sloan Kettering Cancer Center

0 references

Wake Forest University

0 references

Cleveland Clinic

0 references

University of Pittsburgh

0 references

minimum age

18 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT02101905

0 references

(Q64189152)

Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)